TITLE

Sedative clearance during extracorporeal membrane oxygenation

AUTHOR(S)
Bhatt-Mehta, Varsha; Annich, Gail
PUB. DATE
November 2005
SOURCE
Perfusion;Nov2005, Vol. 20 Issue 6, p309
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The effects of polyvinyl chloride (PVC) tubing and membrane oxygenator (MO) on the concentrations of lorazepam and morphine in the neonatal extracorporeal membrane oxygenation (ECMO) circuit were evaluated using an in vitro model that included a closed ECMO circuit with a MO, heat exchanger, bladder and PVC tubing. The circuit was primed with blood, electrolytes, albumin and heparin and maintained at physiologic pH and temperature throughout by frequent measurement of blood gas pH and a temperature probe. Lorazepam and morphine were each studied separately in three separate, but identical circuits for 6 h on the day of circuit prime (new circuit) and then again for 6 h at 24 h (old circuit). Each circuit (new and old) was spiked once with lorazepam to a final concentration of 250 ng/mL or with morphine to a final concentration of 70 ng/mL in the circuit. Serial samples were drawn at baseline and every 30–60 min for 6 h at the site of injection and pre- and post-MO for each circuit. Lorazepam and morphine concentrations were analysed using gas chromatography with electron capture and gas chromatography with mass spectrometry, respectively. The concentrations of morphine and lorazepam at various sample sites and time points were expressed as a percentage of the original concentration. This single-dose study shows that up to 50% of a dose of lorazepam and 40% of a dose of morphine may be extracted by PVC and MO during bypass, depending on the age of the circuit. As the circuits become older, this amount could increase. These data may explain, in part, the higher doses of lorazepam and morphine required to sedate patients during ECMO.
ACCESSION #
18826224

 

Related Articles

  • The potential of accurate SVO2 monitoring during venovenous extracorporeal membrane oxygenation: an in vitro model using ultrasound dilution. Walker, Joshua; Primmer, Johanna; Searles, Bruce E.; Darling, Edward M. // Perfusion;Jul2007, Vol. 22 Issue 4, p239 

    Introduction. Some degree of recirculation occurs during venovenous extracorporeal membrane oxygenation (VV ECMO) which, (1) reduces oxygen (O2) delivery, and (2) renders venous line oxygen saturation monitoring unreliable as an index of perfusion adequacy. Ultrasound dilution allows clinicians...

  • Extracorporeal Membrane Oxygenation: Quo Vadis? Betit, Peter // Respiratory Care;Jul2009, Vol. 54 Issue 7, p948 

    Extracorporeal membrane oxygenation, a form of artificial circulatory support, continues to evolve beyond its well-established neonatal applications. It is often the most aggressive aspect of treatment algorithms in the management of severe respiratory and cardiac failure. While its use is...

  • Safety of recombinant factor VIIa in patients under extracorporeal membrane oxygenation. Anselmi, Amedeo; Guinet, Patrick; Ruggieri, Vito Giovanni; Aymami, Marie; Lelong, Bernard; Granry, Solène; Malledant, Yannick; Le Tulzo, Yves; Gueret, Pierre; Verhoye, Jean-Philippe; Flecher, Erwan // European Journal of Cardio-Thoracic Surgery;Jan2016, Vol. 49 Issue 1, p78 

    OBJECTIVES: To address the safety (rate of thromboembolic events and circuit complications) and efficacy (rate of bleeding control) of recombinant activated coagulation factor VII (rFVIIa) to treat severe bleeding refractory to all surgical and medical treatments in patients under veno-arterial...

  • Developmental outcome in newborn infants treated for acute respiratory failure with extracorporeal membrane oxygenation: present experience. Khambekar, K.; Nichani, S.; Luyt, D. K.; Peek, G.; Firmin, R. K.; Field, D. J.; Pandya, H. C. // Archives of Disease in Childhood -- Fetal & Neonatal Edition;Jan2006, Vol. 91 Issue 1, pF21 

    Objective: To describe the later health status of newborn infants who received extracorporeal membrane oxygenation (ECMO) for acute respiratory failure in the era after the UK ECMO trial. Design: Prospective follow up study of newborn infants who received ECMO at a single centre between January...

  • A comparison of radiographic signs of pulmonary inflammation during ECMO between silicon and poly-methyl pentene oxygenators. Khoshbin, Espeed; Dux, Anthony E. W.; Killer, Hilliary; Sosnowski, Andrzej W.; Firmin, Richard K.; Peek, Giles J. // Perfusion;Jan2007, Vol. 22 Issue 1, p15 

    Introduction: The inflammatory response caused by extracorporeal membrane oxygenation (ECMO) is clearly visible within the first 24 h of cannulation. The inflammatory process affects all areas of the lung, even areas previously spared by the primary disease. Objective: To compare the change in...

  • extracorporeal gas exchange. Peters, Michael // BMA A-Z Family Medical Encyclopedia;2004, p289 

    An encyclopedia entry for "extracorporeal gas exchange" is presented. The term refers to a method of diverting blood out of the body and through an artificial lung to assist respiration. The method involves extracorporeal membrane oxygenation (ECMO), a procedure wherein blood is passed over an...

  • A potential propensity for failure secondary to clot embolism in neonatal ECMO. Khoshbin, Espeed; Machin, David; Killer, Hilliary; Peek, Giles J; Sosnowski, Andrzej W; Firmin, Richard K // Perfusion;May2005, Vol. 20 Issue 3, p177 

    Objective: To report a single case of oxygenator failure caused by clot embolism originating from the bladder; and to discuss some preventative options. Case report: A 2.5 kg neonate with a diagnosis of influenza A received veno-arterial (V–A) extracorporeal membrane oxygenation (ECMO)...

  • The use of continuous renal replacement therapy in series with extracorporeal membrane oxygenation. Santiago, Maria J.; Sánchez, Amelia; López-Herce, Jesús; Pérez, Rosario; del Castillo, Jimena; Urbano, Javier; Carrillo, Angel // Kidney International;Dec2009, Vol. 76 Issue 12, p1289 

    A large percentage of patients on extracorporeal membrane oxygenation (ECMO) require continuous renal replacement therapy (CRRT) usually performed through a different venous access or by introducing a filter into the ECMO circuit. Here, we evaluated the efficacy and safety of including a CRRT...

  • ECMO and endogenous carboxyhemoglobin formation. Tripathi, Ravi S.; Papadimos, Thomas J. // International Journal of Critical Illness & Injury Science;Jul-Dec2011, Vol. 1 Issue 2, p168 

    The article describes a case of extremely high and poisonous carboxyhemoglobin (COhb) level in a 41-year-old patient on extracorporeal membrane oxygenation (ECMO). The patient presented with shortness of breath and hypoxemia, requiring mechanical ventilation. The patient was given inhaled nitric...

Share

Read the Article

Courtesy of NEW JERSEY STATE LIBRARY

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics